Tokyo University of Pharmacy and Life Sciences · Department of Pharmacy / Faculty of Pharmaceutical Sciences

Research keywordsovarian cancer・tumor microenvironment・deep vein thrombosis・immune evasion・cancer-associated fibroblasts・lipid starvation・tissue factor pathway inhibitor

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• A mouse model of deep vein thrombosis by inferior vena cava hypoperfusion using ameroid constrictors.2025 · Scientific reports
• Tissue factor pathway inhibitor-2 inhibits integrin β1 activation and focal adhesion formation and suppresses peritoneal ovarian cancer dissemination in mice.2024 · Biochemical and biophysical research communications
• Cancer cell-derived CD69 induced under lipid and oxygen starvation promotes ovarian cancer progression via fibronectin.2023 · Cancer science
• がん関連血栓症を含む深部静脈血栓症研究のための下大静脈低灌流による血栓形成マウスモデル(A practical mouse model of thrombosis by hypoperfusion of inferior vena cava for cancer-associated thrombosis research)2023 · 日本癌学会総会記事

• 超音波応答性細胞外小胞ハイブリッドナノバブルの開発と末梢動脈疾患治療への応用2024 · 科学研究費助成事業
• 新規noncoding RNA-L-IST-によるSeP翻訳制御メカニズムの解析2019 · 科学研究費助成事業 基盤研究(C)
• がん細胞由来エクソソーム中IDO1関連代謝物のがん免疫逃避機構おける役割の解明2018 · 科学研究費助成事業 若手研究

• Official profile